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Examining the Relationship between Depression, Anxiety and Stress 
in Kidney Cancer Patients
Türev Demirtaş1, Zekeriya Temircan2
1Department of Medical Ethics and History, Erciyes University School of Medicine, Merkez Kampüs Talas Yolu Melikgazi, Kayseri, Turkey; 
2Department of Psychology, Kapadokya University, Yeni, Ürgüp, Nevşehir, Turkey
Abstract
Cancer of the kidney is one of the 10 most common cancers found globally. Overall, it is the fourth most common cancer in men and the eighth 
most common cancer in women. Many kidney cancer patients experience psychologic problems and reactions. The present study examined 
relationship between anxiety, depression, and perceived stress symptoms in kidney cancer patients. Cross-sectional data were obtained from the 
patients diagnosed with kidney cancer. All participants completed sociodemographic form, Hospital Anxiety and Depression form, and Per-
ceived Stress Scale. Statistical analysis was exercised using the Student’s t-test, Chi-squared test (χ2), Fischer’s exact test, ANOVA, Mann–Whit-
ney U test, and Kruskal–Wallis one-way variance analysis. A total of 250 patients participated in the study. The mean age was 57.4 years (SD 
6.4, range = 25–76 years). The majority of patients were males (73%) and married (218). Anxiety symptoms were determined in 91.2% patients, 
depression symptoms in 87.2% patients, and perceived stress symptoms in 93.6% patients. The mean scores of Hospital Depression and Anxiety 
Scale (HADS)-Anxiety, HADS-Depression, and HADS-Perceived Stress were significantly different between age (P < 0.05), gender (P < 0.05), 
and income groups (P < 0.001). Kidney cancer patients showed poorer psychologic health. The overall levels of anxiety, depression, and per-
ceived stress symptoms were higher among the studied kidney cancer patients. Findings of the current study could improve both psychologic 
well-being of patients and health-related quality of life.
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Cancer of the kidney is one of the 10 most common diag-
nosed cancers worldwide. Overall, it is the fourth most com-
mon cancer in men and the eighth most common cancer in 
women (1). Studies have reported that prevalence of psy-
chologic disorders and problems in kidney cancer patients 
is high (2). Owing to increasing lifestyle factors, such as age, 
gender, smoking, alcohol, obesity, and environmental and 
genetic factors, the patients are at higher risk of developing 
severe stress, depression, and anxiety (3). These factors and 
severe trauma have contributed to many psychologic prob-
lems in kidney cancer patients. Not only lifestyle factors but 
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also stressful issues during the treatment have negative influ-
ence on patients’ quality of life. Recent studies have stated 
that increasing cancer cases are associated with different risk 
factors (4). However, it is important to investigate the effects 
of cancer in patients with many psychopathologies. It is well 
known that diagnosis and treatment of kidney cancer are very 
stressful issues for patients as well as family members. Accord-
ing to a study (5), two-thirds of patients who are mechanically 
ventilated experience high levels of stress and depression than 
their counterparts. The studies have also shown an association 
between patients’ prolonged mechanical ventilation and psy-
chologic comorbidities such as depression, anxiety, and stress 
(6, 7). Another study reported that patients who had a longer 
treatment period experienced an increased risk of developing 
psychologic problems (8). There is growing evidence that can-
cer patients are at risk of developing psychologic problems 
such as stress, depression, and anxiety (9). 
It is important to support cancer patients psychologically 
as well as psychosocially in order to achieve successful treat-
ment process and improve quality of life. Although some 
attention has been paid to the increasing prevalence of psy-
chologic disorders occurring in kidney cancer patients, there 
are limited data and research on relationship between stress, 
depression, and anxiety and kidney cancer. The results of 
these studies on kidney cancer patients are very limited in 
literature. Therefore, this study aimed to present fresh data 
by examining relationship between depression, anxiety, and 
stress in kidney cancer patients.
Method 
A total of 250 patients with diagnosed kidney cancer par-
ticipated in the study. All participants completed sociode-
mographic questionnaire, Hospital Depression and Anxiety 
Scale (HADS), and Perceived Stress Scale (PSS). The socio-
demographic form included patient’s personal information, 
including age, gender, marital status, education, income, 
occupation, chronic disease, health-related questions, and 
the type of surgical procedure being performed. 
The HADS is commonly used to measure anxiety and 
depression levels of patients. It comprises 14 items and 
measures both anxiety (HADS-Anxiety) and depression 
(HADS-Depression) levels with an equal number of ques-
tions. Patients rank questions on a Likert scale, ranging 
from 0 to 3, and the subscale from 0 to 21. A total score of 
8 or above was defined as an optimal cut-off  score for level 
of comfort for both anxiety and depression. In a reliability 
study of the Turkish version of HADS, Cronbach’s alpha 
coefficient was found as 0.8525 for the anxiety subscale and 
0.7784 for the depression subscale. The total correlation 
score of coefficient in the anxiety subscale was between 0.816 
and –0.854, and that in the depression subscale was between 
0.737 and –0.779.
The Perceived Stress Scale (PSS-10) which was validated 
and translated into Turkish by Eskin et al. (2013) was used 
to assess stress level. The Turkish version was also found to 
have adequate reliability and validity for measuring stress 
levels. The PSS-10 is about feelings and thoughts reflected by 
participants on their current life situations. This is a Likert 
scale to measure the level of stress (0 = never, 1 = almost 
never, 2 = sometimes, 3 = fairly often, and 4 = very often). 
Thus, the higher score shows higher level of stress. The scale 
correlates with depression and perception of poorer health 
quality. 
Statistical Analysis
Data were analyzed by SPSS statistical package program ver-
sion 23. In statistical evaluation, Student’s t-test was used for 
quantitative variables, and numbers, percentage, mean value, 
and standard deviation were calculated. Chi-squared test 
(χ2), Fischer’s Exact test, ANOVA, Mann–Whitney U test, 
and Kruskal–Wallis one-way variance analysis were used. P 
< 0.05 was considered as statistically significant. 
Ethical Consideration
This study obtained ethical approval from the Erciyes Uni-
versity Medical School Ethic Committee, and Helsinki Dec-
laration guidelines were followed during the study.
Results 
A total of 250 patients participated in the study. The mean 
age was 57.4 years (SD 6.4, range = 25–76 years). The major-
ity of patients were males (73%) and married (218). More 
than half  of the participants were aged between 25 and 50 
years, and educated up to primary (36.8%) and secondary 
school levels. Nearly two-thirds of participants reported 
a monthly income of 2001–5000 Turkish Lira (TL). The 
majority of participants (66%) were not working or were 
retired, and were nonsmokers (79.2%). As for the health or 
clinical characteristics, 59.2% of the participants did not 
have surgery, 71.2% did not have cancer in the family, and 
74% of them did not have other chronic diseases (Table 1).
The mean scores of the anxiety and depression sub-
scales were 1.9 (SD = 2.9) and 1.8 (SD = 2.5), respectively. 
The mean score of the distress subscale was 2.1 (SD = 2.8). 
HADS-Anxiety symptoms in the study were found in 91.2% 
patients; 98 (39.2%) participants had mild, 99 (39.6%) had 
moderate, 31 (12.4%) had severe, and 22 (8.8%) had no anx-
iety symptoms. HADS-Depression symptoms in the study 
were found in 87.2% patients; 87 (34.8%) participants had 
mild, 101 (40.4%) had moderate, 30 (12%) had severe, and 32 
(12.8%) had no depression symptoms. PSS-Stress symptoms 
in the study were found in 93.6% patients, with 176 (69.6%) 
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Table 1: Socio-demographic characteristics of participants  
(n = 250).
n %
Age (years) 25–50 148 59.2
50 and above 102 40.8






Education Primary 92 36.8
Secondary 67 26.8
High School 48 19.2
University and above 43 17.2
Income (TL) <2000 71 28.4
 2001–5000 141 56.4
>5001 38 15.2
Smoking Yes 52 20.8
No 198 79.2





Not working or retired 165 66









participants having moderate, 60 (24%) having high, and 14 
(6.4) having low or no stress symptoms.
Table 2 presents comparison of the mean scores and total 
sample numbers of HADS-Anxiety, HADS-Depression, 
PSS-Stress, and sociodemographic variables. The mean 
scores of HADS-Anxiety (independent t-test (t) = –1.87, 
P  = 0.01), HADS-Depression (t = –1.77, P = 0.04), and 
PSS-Stress (t = 2.54, P = 0.02) were significantly different 
between age groups. The mean scores of HADS-Anxiety 
(t = 0.91, P = 0.01), HADS-Depression (t = 1.02, P = 0.02), 
and PSS-Stress (t = 0.067, P = 0.02) were significantly 
Table 2: Anxiety, depression, and perceived stress in kidney 
cancer patients (n = 250).
  n %
HADS-Anxiety
 No anxiety 22 8.8
 Mild 98 39.2
 Moderate 99 39.6
 Severe 31 12.4
HADS-Depression
 No depression 32 12.8
 Mild 87 34.8
 Moderate 101 40.4
 Severe 30 12
PSS-Stress
 Low 14 6.4
 Moderate 176 69.6
 High 60 24
different between genders. Likewise, mean scores of 
HADS-Anxiety (t = 2.87, P = 0.01), HADS-Depression (t 
= 2.38, P = 0.02), and PSS-Stress (t = 3.12, P = 0.01) were 
significantly different between income groups. Participants 
aged ≥50 years, having primary and above education, and 
were not employed or retired reported significantly poor 
psychologic well-being than their younger, higher edu-
cated, and employed counterparts. Females reported poorer 
HADS-Anxiety and HADS-Depression scores as compared 
to males; however, males reported poorer PSS-Stress scores 
than females. Single participants reported low mean scores 
in HADS-Anxiety, HADS-Depression, and PSS-Stress scales 
as compared to married participants. In addition, smok-
ers and those with other chronic diseases reported poorer 
HADS-Anxiety, HADS-Depression, and PSS-Stress scores 
as compared to nonsmokers and participants not having 
other chronic diseases. Finally, participants having can-
cer patients in their family reported high mean scores in 
HADS-Anxiety, HADS-Depression, and PSS-Stress than 
their counterparts having no cancer patients in their family 
(Table 3).
Discussion 
The results of the current study indicate that psychologic 
disorders of anxiety, depression, and stress, with their 
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subscales, appeared in nearly 90% of patients with kidney 
cancer. Kidney cancer patients may experience any level of 
anxiety, depression, and distress at any stage of their disease 
after diagnosis. It is assumed that cancer is a serious disease 
and causes many psychologic problems. In the current study, 
HADS-Anxiety, HADS-Depression, and PSS-Stress scores 
were used to screen kidney cancer patients. The prevalence of 
anxiety, depression, and perceived stress symptoms were high 
in these patients. Significantly greater anxiety, depression, and 
perceived stress symptoms were specifically reported in rela-
tion to age, gender, income, and sociodemographic variables. 
An increase in psychiatric morbidity has been reported in 
cancer patients, and the prevalence of psychiatric diseases 
has been found to vary in a wide range of 9–60% (10). In 
the current study, the percentage of anxiety, depression, 
and perceived stress in kidney cancer patients was consid-
erably higher compared to the data available in literature. It 
was found in literature that most patients remained anxious 
due to the process of treatment, stage of cancer, thoughts 
of death, extended hospital stay, and other health compli-
cations (11). Li and Wang reported that 77.6% of Chinese 
kidney cancer patients had depressive symptoms and 68.3% 
of them had anxiety symptoms because of series of negative 
emotions, confronting progressive illness, and longer treat-
ment period (12). Supportively, Cohen et al. indicated that 
23% of kidney cancer patients in the United States experi-
enced depressive symptoms (13).
A systematic observational study conducted on the prev-
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Figure 1: Distribution of anxiety, depression, and perceived stress in kidney cancer patients (n = 250).
that cancer diagnosis and treatment interact with the level 
of anxiety and psychologic state of the patient, thereby neg-
atively affecting patient’s current illness, fight with the dis-
ease, compliance with the treatment, and quality of life (14). 
Henningsohn et al. reported that 35% of cancer patients had 
depressive symptoms and 20% of them had anxiety symp-
toms after surgery (15). Relatively, Ficarra et al. showed 
that 22% of the patients with urologic malignancy experi-
enced depressive symptoms and 14% of them had anxiety 
symptoms (16). Another study (17) has reported that age is 
associated with the risk for anxiety and distress, as younger 
patients tend to worry more about cancer and the manner 
of treatment. Generally, young and middle-aged cancer 
patients, females, and those receiving chemotherapy have 
higher levels of anxiety and distress. The study reported that 
the highest rate of anxiety and distress was found in patients 
aged 18–40 years. Findings of the current study are consis-
tent with the above-mentioned results, as age and gender are 
linked to anxiety, depression, and perceived stress in kidney 
cancer patients. 
Income was identified as one of three predictors of higher 
risk of anxiety, depression, and perceived stress in kidney 
cancer patients. The study conducted by Sanfilippo et al. 
revealed that cancer patients from low-income group expe-
rience more psychologic problems because of lack of access 
to medical care, medicines, and not getting enough treatment 
after diagnosis (18). Inability to access medical resources is 
associated with more psychologic problems in these patients. 
Findings of the current study are consistent with those found 
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Table 3: Comparison of mean scores of HADS-Anxiety, HADS-Depression, PSS-Stress, and socio-demographic characteristics 
(n = 250).
n HADS-Anxiety Mean (SD) HADS-Depression Mean (SD) PSS-Stress Mean (SD)
Age (years)
25_50 148 1.4 (1.8) 1.2 (2.0) 1.17 (2.34)
50 and above 102 2.1 (3.2) 2.0 (2.8) 2.1 (2.98)
t –1.87 –1.77 2.54
P-value   0.01 0.04 0.02
Gender
Male 184 1.7 (2.8) 1.7 (2.5) 2.1 (2.8)
Female 66 4.0 (4.8) 2.8 (2.6) 1.8 (2.4)
t 0.91 1.02 0.067
P-value   0.01 0.02 0.02
Marital Status
Single 32 2.2 (3.3) 2.1 (2.8) 2.6 (3.2)
Married 218 1.6 (2.7) 1.5 (1.4) 1.8 (2.6)
t 0.41 0.43 0.87
P-value   0.672 0.322 0.812
Education
Primary 92 3.8 (2.6) 2.4 (2.2) 2.9 (4.4)
Secondary 67 0.9 (1.2) 1.0 (1.8) 1.5 (2.2)
High School 48 1.7 (2.6) 1.1 (1.6) 1.9 (2.7)
University and above 43 2.0 (3.5) 2.2 (2.6) 2.4 (3.4)
F 0.29 0.09 3.12
P-value   0.18 0.91 0.01*
Income (TL)
<2000 71 2.2 (1.4) 2.6 (1.7) 2.2 (1.6)
 2001–5000 141 2.0 (1.5) 2.4 (1.5) 2.1 (1.6)
>5001 38 2.6 (1.4) 2.2 (1.7) 2.3 (1.4)
t 2.87 2.38 3.12
P-value   <0.01** 0.02* 0.01
(Continues)
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Table 3: Continued
n HADS-Anxiety Mean (SD) HADS-Depression Mean (SD) PSS-Stress Mean (SD)
Smoking
Yes 52 5.1 (5.2) 2.6 (1.5) 1.8 (1.8)
No 198 3.0 (4.9) 2.1 (1.2) 1.4 (2.2)
t –0.45 –0.344 –1.91
P-value   0.29 0.417 0.812
Surgery
Yes 102 3.5 (4.8) 3.2 (4.2) 2.8 (4.1)
No 148 3.2 (4.4) 2.7 (3.8) 3.0 (5.2)
t 0.718 0.578 0.612
P-value   0.772 0.812 0.433
Employment Status
Working 85 2.0 (3.2) 1.8 (3.2) 1.6 (2.0)
Not working or retired 165 3.1 (4.4) 2.5 (3.6) 1.8 (2.8)
t –0.221 –0.239 –0.518
P-value   0.918 0.377 0.617
Cancer in the family
Yes 72 3.9 (5.6) 3.2 (3.0) 2.7 (4.1)
No 178 2.7 (1.5) 1.6 (2.5) 1.5 (2.1)
t 0.59 0.678 0.805
P-value   0.122 0.433 0.718
Other chronic diseases
Yes 185 4.4 (6.2) 4.1 (5.8) 3.8 (2.6)
No 65 3.5 (4.0) 2.6 (1.4) 2.8 (3.2)
t 0.481 0.756 0.32
P-value   0.245 0.456 0.978
t: Independent t-test; F: One way ANOVA; TL: Turkish Lira. 
*Significant level at 0.05; **significant level at 0.01.
in literature, as income is considered as one of the predictors 
in kidney cancer patients liked to anxiety, depression, and 
perceived stress symptoms. Recent studies have indicated that 
low education and income and lack of psychologic resilience 
are the risk factors for depressive and anxiety symptoms (19). 
Another study has reported that individuals affected by can-
cer face decreased ability to keep their lives under control, 
have increased dependency on others, with deteriorating 
balance in family, work, and social life (20). Thus, cancer 
patients experience greater level of anxiety, depression, dis-
tress, and other psychosocial problems. Therefore, at social 
level, concerns may arise about their relationships with fam-
ily members, healthcare professionals, and social network. 
Although participants in the current study demonstrated a 
higher risk of anxiety, depression, and perceived stress symp-
toms, prior studies have reported that patients with breast, 
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function, long-term survival, and use of surgery in patients with 
kidney cancer.  Cancer.  2016;122(24):3776–3784. https://doi.
org/10.1002/cncr.30275
4. Milbury K, Lopez G, Spelman A, Wood C, Matin SF, 
Tannir  NM, et al. Examination of moderators of expressive 
writing in patients with renal cell carcinoma: The role of depres-
sion and social support.  Psychooncol.  2017;26(9):1361–1368. 
https://doi.org/10.1002/pon.4148
5. Greenberg JH, Coca S, Parikh CR. Long-term risk of chronic 
kidney disease and mortality in children after acute kidney 
injury: A systematic review. BMC Nephrol. 2014;15:184. https://
doi.org/10.1186/1471-2369-15-184
6. Bhaskar P, Dhar AV, Thompson M, Quigley R, Modem V. Early 
fluid accumulation in children with shock and ICU mortality: A 
matched case-control study. Intensive Care Med. 2015;41:1445–
1453. https://doi.org/10.1007/s00134-015-3851-9
7. Axelrod DM, Anglemyer AT, Sherman-Levine SF, Zhu A, 
Grimm PC, Roth SJ, et al. Initial experience using aminophyl-
line to improve renal dysfunction in the pediatric cardiovascu-
lar ICU. Pediatr Crit Care Med. 2014;15:21–27. https://doi.
org/10.1097/01.pcc.0000436473.12082.2f
8. Chawla LS, Davison DL, Brasha-Mitchell E, Koyner JL, 
Arthur JM, Shaw AD, et al. Development and standardization 
of a furosemide stress test to predict the severity of acute kidney 
injury. Crit Care. 2013;17:R207. https://doi.org/10.1186/cc13015
9. Selewski DT, Symons JM. Acute kidney injury. Pediatr Rev. 
2014;35:30–41. https://doi.org/10.1542/pir.35-1-30
10. Schmidt LS, Linehan WM. Genetic predisposition to kid-
ney cancer.  Sem Oncol.  2016;43(5):566–574. https://doi.
org/10.1053/j.seminoncol.2016.09.001
11. Miao T, Li Y, Sheng X, Yao D. Marital status and survival of 
patients with kidney cancer. Oncotarget. 2017;8(49):86157–
86167. https://doi.org/10.18632/oncotarget.21029
12. Li M, Wang L. The associations of psychological stress with 
depressive and anxiety symptoms among Chinese bladder and 
renal cancer patients: The mediating role of resilience. PLoS 
One. 2016;11(4):e0154729. https://doi.org/10.1371/journal.
pone.0154729
13. Cohen M, Baziliansky S, Beny A. The association of resilience 
and age in individuals with colorectal cancer: An exploratory 
cross-sectional study. J Geriatr Oncol. 2014;5:33–39. https://doi.
org/10.1016/j.jgo.2013.07.009. PMID: 24484716.
14. Harvey-Kelly L, Harrison H, Rossi SH, Griffin SJ, Stewart GD, 
Usher-Smith JA. Public attitudes towards screening for kidney 
cancer: An online survey.  BMC Urol.  2020;20(1):170. https://
doi.org/10.1186/s12894-020-00724-0
15. Henningsohn L, Wijkström H, Pedersen J, Ahlstrand C, Aus G, 
Bergmark K, et al. Time after surgery, symptoms and well-being 
in survivors of urinary bladder cancer. BJU Int. 2003;91:325–
330. https://doi.org/10.1046/j.1464-410X.2003.04101.x. PMID: 
12603405. 
16. Ficarra V, Righetti R, D`Amico A, Pilloni S, Balzarro M, 
Schiavone D, et al. General state of health and psychologi-
cal well-being in patients after surgery for urological malig-
nant neoplasms. Urol Int. 2000;65:130–134. https://doi.
org/10.1159/000064857. PMID:11054029.
17. Tseng CH. Type 2 diabetes mellitus and kidney cancer risk: A 
retrospective cohort analysis of the National Health Insurance. 
PloS One. 2015;10(11):e0142480. https://doi.org/10.1371/jour-
nal.pone.0142480
prostate, and lung cancers also demonstrate having these 
psychologic problems during the process of illness (21, 22).
Conclusion
This is the first study to examine relationships of psychologic 
anxiety, depression, and stress in kidney cancer patients in 
Turkey. The results of this study provided knowledge on psy-
chologic problems such as anxiety, depression, and perceived 
stress symptoms in kidney cancer patients. Our findings 
revealed that age, gender, and income mainly affected depres-
sive, anxiety, and stress symptoms in kidney cancer patients. 
Results incurred in the present study were in accordance with 
literature findings on kidney cancer and psychologic prob-
lems. Hence, it is important for hospitals to create feasible 
and positive strategies to promote psychologic resilience of 
kidney cancer patients. It is also important to improve their 
emotional and psychologic well-being as well as increase 
their quality of life. 
Implications
This is the first study in Turkey to evaluate psychologic prob-
lems such as anxiety, depression, and stress in kidney cancer 
patients. Findings of this study have practical implications to 
cope with psychologic problems. The findings revealed that 
kidney cancer patients not only suffer from cancer but also 
from psychologic problems. Further studies must focus at 
exploring whether psychologic interventions and cancer-re-
lated education could help patients to cope with cancer and 
its psychologic symptoms. 
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